Cardiff Lexingto (CDIXD) Financials
Newest figures come from the 10-Q for Q1 FY2026, filed May 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CDIXD SEC filings page.
Cardiff Lexingto (CDIXD) reported $10.8M in revenue over the twelve months to Mar 31, 2026, up 22.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue recovered in FY2025, but heavier interest and working-capital pressure kept the business loss-making and financially stretched.
Revenue rose39.5% from FY2024 and gross margin expanded 8.9 percentage points, indicating that the operating model recovered partway. Yet interest expense rose124.0% while net income was a loss of$5.5M , so the improvement did not flow through to the bottom line.
Cash conversion remains weak: operating cash flow was
Leverage is reshaping the balance sheet: long-term debt increased from
Financial Health Signals
We do not publish a peer-relative financial health score for Cardiff Lexingto, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Cardiff Lexingto passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Cardiff Lexingto reported a net loss of $5.5M while operations used $2.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Cardiff Lexingto earns $0.16 in operating income for every $1 of interest expense ($1.1M vs $6.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Cardiff Lexingto generated $2.2M in revenue in Q1 2026. This represents a decrease of 23.8% from the same quarter a year earlier. Against the prior quarter it is down 19.8%.
Cardiff Lexingto's EBITDA was -$511K in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 193.3% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cardiff Lexingto reported a net loss of $3.1M in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Cardiff Lexingto held $684K in cash as of Q1 2026; no long-term debt figure is on record for that period.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
Cardiff Lexingto's gross margin was 59.3% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 3.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.2 percentage points.
Cardiff Lexingto's operating margin was -23.0% in Q1 2026, reflecting core business profitability. This is down 41.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.1 percentage points.
Cardiff Lexingto's quarterly ROE was -79.8% in Q1 2026: one quarter's net income over shareholder equity, not annualized. This is down 57.6 percentage points from the same quarter a year earlier.
Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
None of these metrics is reported for Q1 2026.
CDIXD Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'25 | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2M-23.8% | $2.8M-11.2% | $3.1M+125.6% | $2.8M+89.5% | $2.9M+25.6% | $3.1M+31.3% | $1.4M-60.2% | $1.5M-56.3% |
| Cost of Revenue | $904K-15.9% | $1.0M-8.0% | $1.1M+14.8% | $1.1M+37.9% | $1.1M+13.4% | $1.1M+13.2% | $1.0M+81.5% | $793K-26.7% |
| Gross Profit | $1.3M-28.4% | $1.8M-12.9% | $1.9M+437.8% | $1.7M+149.8% | $1.8M+34.0% | $2.0M+43.8% | $355K-87.6% | $679K-70.3% |
| SG&A Expenses | $1.2M-9.1% | $1.8M+27.7% | $1.2M+30.7% | $987K+18.3% | $1.3M+50.4% | $1.4M+46.8% | $937K+62.2% | $835K+57.5% |
| Operating Income | -$511K-194.0% | -$696K-309.6% | $643Kn/m | $610Kn/m | $544K+148.4% | $332K-19.9% | -$585K-125.7% | -$159K-109.1% |
| EBITDA | -$511K-193.3% | -$696K-307.3% | $644Kn/m | $610Kn/m | $547K+146.1% | $336K-20.9% | -$582K-125.6% | -$156K-108.9% |
| Interest Expense | $1.9M+92.4% | $2.2M+47.5% | $1.8M+27.4% | $1.8M+4340.6% | $993K+824.2% | $1.5Mn/m | $1.4M+513.0% | $41K-95.1% |
| Net Income | -$3.1Mn/m | -$2.7Mn/m | -$1.1Mn/m | -$1.2Mn/m | -$451Kn/m | -$910K-468.9% | -$2.0M-199.8% | -$132K-116.1% |
| EPS (Basic) | -$0.23 | N/A | -$0.07n/m | -$0.08 | -$0.14n/m | N/A | -$0.16 | -$0.04 |
| EPS (Diluted) | -$0.23 | N/A | -$0.07n/m | -$0.08 | -$0.14n/m | N/A | -$0.16 | -$0.04 |
| Diluted Shares (Avg) | 15M | N/A | 20M+40.4% | 19M | 5M+33.7% | N/A | 14M | 13M |
Not reported in any period shown, so not listed: R&D Expenses, Income Tax.
CDIXD Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'25 | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.3M+19.6% | $29.1M+21.6% | $27.6M+17.4% | $26.5M+7.3% | $25.3M+12.1% | $23.9M+15.3% | $23.5M+27.0% | $24.7M+53.9% |
| Current Assets | $23.9M+28.2% | $22.6M+31.3% | $21.0M+25.6% | $19.9M+10.0% | $18.6M+17.0% | $17.2M+21.4% | $16.8M+39.2% | $18.1M+88.0% |
| Cash & Equivalents | $684K-31.4% | $319K-73.2% | $232K-88.1% | $560K-82.5% | $997K-20.5% | $1.2M+37.1% | $1.9M+975.8% | $3.2M+682.8% |
| Accounts Receivable | $22.9M+30.8% | $22.1M+38.5% | $20.7M+39.9% | $19.2M+29.2% | $17.5M+19.5% | $15.9M+19.8% | $14.8M+24.9% | $14.9M+61.6% |
| Goodwill | $5.7M0.0% | $5.7M0.0% | $5.7M0.0% | $5.7M0.0% | $5.7M0.0% | $5.7M0.0% | $5.7M0.0% | $5.7M0.0% |
| Total Liabilities | $24.6M+35.1% | $26.0M+22.5% | $22.6M+14.2% | $20.5M+44.7% | $18.2M-14.8% | $21.2M+6.1% | $19.8M+10.9% | $14.2M-17.6% |
| Current Liabilities | $24.4M+36.1% | $25.8M+62.6% | $22.4M+52.9% | $20.3M+46.1% | $17.9M+19.3% | $15.9M+14.6% | $14.6M+23.1% | $13.9M+20.8% |
| Non-Current Liabilities | $272K-19.4% | $182K-96.6% | $215K-95.8% | $249K-20.1% | $337K-94.7% | $5.4M-13.0% | $5.1M-13.5% | $312K-94.6% |
| Long-Term Debt | N/A | $18.6M+101.5% | $15.1M+83.4% | $13.1M+77.9% | $10.7M+185.9% | $9.2M+303.8% | $8.2M+4753.3% | $7.4M+4252.2% |
| Total Equity | $3.9M+90.4% | -$2.5M-192.0% | -$364K-109.8% | $754K-87.2% | $2.0M+68.3% | $2.7M+267.1% | $3.7M+451.9% | $5.9Mn/m |
| Retained Earnings | -$82.9Mn/m | -$79.5Mn/m | -$76.5Mn/m | -$75.1Mn/m | -$73.6Mn/m | -$72.9Mn/m | -$71.8Mn/m | -$69.6Mn/m |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments.
CDIXD Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'25 | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$17Kn/m | -$390Kn/m | -$574Kn/m | -$1.4Mn/m | -$491Kn/m | -$723Kn/m | -$908Kn/m | -$100Kn/m |
| Depreciation & Amortization | $593-82.4% | $762-77.4% | $762-77.4% | $763-77.3% | $3K0.0% | $3K-64.2% | $3K0.0% | $3K0.0% |
| Stock-Based Compensation | $664Kn/m | N/A | $41Kn/m | $98Kn/m | $0-100.0% | N/A | $0n/m | $0n/m |
| Financing Cash Flow | $382K+27.2% | $476Kn/m | $247Kn/m | $961K-53.0% | $300K-77.1% | -$39K-102.1% | -$339K-589.2% | $2.0M+1064.1% |
| Dividends Paid | $0-100.0% | $0n/m | $0n/m | $0-100.0% | $50Kn/m | $0-100.0% | $0 | $100K |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Investing Cash Flow, Share Buybacks.
CDIXD Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'25 | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.3%-3.8pp | 63.5%-1.2pp | 62.4%+36.2pp | 60.8%+14.7pp | 63.1%+4.0pp | 64.8%+5.6pp | 26.2%-57.6pp | 46.1%-21.7pp |
| Operating Margin | -23.0%-41.7pp | -25.1%-35.8pp | 21.0%+64.2pp | 21.9%+32.7pp | 18.7%+9.2pp | 10.6%-6.8pp | -43.2%-109.9pp | -10.8%-62.8pp |
| Net Margin | -139.1% | -96.9%-67.7pp | -37.4% | -44.0%-35.0pp | -15.5%-3.3pp | -29.2%-39.6pp | -145.9% | -8.9%-33.2pp |
| Return on Equity | -79.8%-57.6pp | N/A | N/A | -162.7%-160.5pp | -22.1%+1.3pp | -33.9%-67.6pp | -53.0%-346.3pp | -2.2% |
| Return on Assets | -10.2%-8.4pp | -9.2%-5.4pp | -4.1%+4.3pp | -4.6%-4.1pp | -1.8%-0.5pp | -3.8%-5.0pp | -8.4%-19.1pp | -0.5%-5.6pp |
| Current Ratio | 0.98-0.1x | 0.87-0.2x | 0.94-0.2x | 0.98-0.3x | 1.040.0x | 1.08+0.1x | 1.14+0.1x | 1.30+0.5x |
| Debt-to-Equity | N/A | N/A | N/A | 17.39+16.1x | 5.26+2.2x | 3.43+0.3x | 2.20+2.0x | 1.25 |
| Liabilities-to-Equity | 6.35-2.6x | N/A | N/A | 27.26+24.8x | 8.95-8.7x | 7.91-19.5x | 5.31-21.1x | 2.41 |
| Asset Turnover | 0.070.0x | 0.100.0x | 0.11+0.1x | 0.110.0x | 0.120.0x | 0.130.0x | 0.06-0.1x | 0.06-0.2x |
Not reported in any period shown, so not listed: FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Note: Shareholder equity is negative (-$2.5M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.87), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where Cardiff Lexingto Ranks
Frequently Asked Questions
Cardiff Lexingto (CDIXD) reported $11.5M in total revenue for fiscal year 2025. This represents a 39.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Cardiff Lexingto (CDIXD) revenue grew by 39.5% year-over-year, from $8.3M to $11.5M in fiscal year 2025.
No, Cardiff Lexingto (CDIXD) reported a net loss of $8.1M over the trailing 12 months to March 31, 2026. In fiscal year 2025 it reported a net loss of $5.5M, with a net profit margin of -47.7%.
Cardiff Lexingto (CDIXD) had EBITDA of $1.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Cardiff Lexingto (CDIXD) had $319K in cash and equivalents against $18.6M in long-term debt.
Cardiff Lexingto (CDIXD) had a gross margin of 62.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Cardiff Lexingto (CDIXD) had an operating margin of 9.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Cardiff Lexingto (CDIXD) had a net profit margin of -47.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Cardiff Lexingto (CDIXD) recorded an outflow of $2.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Cardiff Lexingto (CDIXD) had $29.1M in total assets as of fiscal year 2025, including both current and long-term assets.
Cardiff Lexingto (CDIXD) had a current ratio of 0.87 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Cardiff Lexingto (CDIXD) had a return on assets of -18.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Cardiff Lexingto (CDIXD) has negative shareholder equity of -$2.5M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Cardiff Lexingto (CDIXD) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Cardiff Lexingto (CDIXD) reported a net loss of $5.5M while operations used $2.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Cardiff Lexingto (CDIXD) has an interest coverage ratio of 0.16x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.